278 related articles for article (PubMed ID: 17218988)
1. Targeting TACE-dependent EGFR ligand shedding in breast cancer.
Kenny PA; Bissell MJ
J Clin Invest; 2007 Feb; 117(2):337-45. PubMed ID: 17218988
[TBL] [Abstract][Full Text] [Related]
2. Hormone-induced expression of tumor necrosis factor alpha-converting enzyme/A disintegrin and metalloprotease-17 impacts porcine cumulus cell oocyte complex expansion and meiotic maturation via ligand activation of the epidermal growth factor receptor.
Yamashita Y; Kawashima I; Yanai Y; Nishibori M; Richards JS; Shimada M
Endocrinology; 2007 Dec; 148(12):6164-75. PubMed ID: 17901238
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer.
Tanaka Y; Miyamoto S; Suzuki SO; Oki E; Yagi H; Sonoda K; Yamazaki A; Mizushima H; Maehara Y; Mekada E; Nakano H
Clin Cancer Res; 2005 Jul; 11(13):4783-92. PubMed ID: 16000575
[TBL] [Abstract][Full Text] [Related]
4. TACE/ADAM-17: a component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer.
Merchant NB; Voskresensky I; Rogers CM; Lafleur B; Dempsey PJ; Graves-Deal R; Revetta F; Foutch AC; Rothenberg ML; Washington MK; Coffey RJ
Clin Cancer Res; 2008 Feb; 14(4):1182-91. PubMed ID: 18281553
[TBL] [Abstract][Full Text] [Related]
5. TACE-dependent TGFα shedding drives triple-negative breast cancer cell invasion.
Giricz O; Calvo V; Peterson EA; Abouzeid CM; Kenny PA
Int J Cancer; 2013 Dec; 133(11):2587-95. PubMed ID: 23729230
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor signaling in hepatocellular carcinoma: inflammatory activation and a new intracellular regulatory mechanism.
Berasain C; Nicou A; Garcia-Irigoyen O; Latasa MU; Urtasun R; Elizalde M; Salis F; Perugorría MJ; Prieto J; Recio JA; Corrales FJ; Avila MA
Dig Dis; 2012; 30(5):524-31. PubMed ID: 23108309
[TBL] [Abstract][Full Text] [Related]
7. Regulated ADAM17-dependent EGF family ligand release by substrate-selecting signaling pathways.
Dang M; Armbruster N; Miller MA; Cermeno E; Hartmann M; Bell GW; Root DE; Lauffenburger DA; Lodish HF; Herrlich A
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9776-81. PubMed ID: 23720309
[TBL] [Abstract][Full Text] [Related]
8. Sheddase activity of tumor necrosis factor-alpha converting enzyme is increased and prognostically valuable in head and neck cancer.
Ge L; Baskic D; Basse P; Vujanovic L; Unlu S; Yoneyama T; Vujanovic A; Han J; Bankovic D; Szczepanski MJ; Hunt JL; Herberman RB; Gollin SM; Ferris RL; Whiteside TL; Myers EN; Vujanovic NL
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2913-22. PubMed ID: 19843672
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of TNF-alpha converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation.
Zhang Q; Thomas SM; Lui VW; Xi S; Siegfried JM; Fan H; Smithgall TE; Mills GB; Grandis JR
Proc Natl Acad Sci U S A; 2006 May; 103(18):6901-6. PubMed ID: 16641105
[TBL] [Abstract][Full Text] [Related]
10. TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells.
Gschwind A; Hart S; Fischer OM; Ullrich A
EMBO J; 2003 May; 22(10):2411-21. PubMed ID: 12743035
[TBL] [Abstract][Full Text] [Related]
11. A transforming Src mutant increases the bioavailability of EGFR ligands via stimulation of the cell-surface metalloproteinase ADAM17.
Maretzky T; Zhou W; Huang XY; Blobel CP
Oncogene; 2011 Feb; 30(5):611-8. PubMed ID: 20871631
[TBL] [Abstract][Full Text] [Related]
12. Involvement of TNF-α converting enzyme in the development of psoriasis-like lesions in a mouse model.
Sato K; Takaishi M; Tokuoka S; Sano S
PLoS One; 2014; 9(11):e112408. PubMed ID: 25384035
[TBL] [Abstract][Full Text] [Related]
13. Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin.
Sternlicht MD; Sunnarborg SW; Kouros-Mehr H; Yu Y; Lee DC; Werb Z
Development; 2005 Sep; 132(17):3923-33. PubMed ID: 16079154
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor alpha (TGF-alpha) and other targets of tumor necrosis factor-alpha converting enzyme (TACE) in murine polycystic kidney disease.
Nemo R; Murcia N; Dell KM
Pediatr Res; 2005 May; 57(5 Pt 1):732-7. PubMed ID: 15774823
[TBL] [Abstract][Full Text] [Related]
15. Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells.
Gilmore JL; Scott JA; Bouizar Z; Robling A; Pitfield SE; Riese DJ; Foley J
Breast Cancer Res Treat; 2008 Aug; 110(3):493-505. PubMed ID: 17882547
[TBL] [Abstract][Full Text] [Related]
16. ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion.
Xiao LJ; Lin P; Lin F; Liu X; Qin W; Zou HF; Guo L; Liu W; Wang SJ; Yu XG
Int J Oncol; 2012 May; 40(5):1714-24. PubMed ID: 22200661
[TBL] [Abstract][Full Text] [Related]
17. Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx.
Horiuchi K; Le Gall S; Schulte M; Yamaguchi T; Reiss K; Murphy G; Toyama Y; Hartmann D; Saftig P; Blobel CP
Mol Biol Cell; 2007 Jan; 18(1):176-88. PubMed ID: 17079736
[TBL] [Abstract][Full Text] [Related]
18. TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase.
Lee DC; Sunnarborg SW; Hinkle CL; Myers TJ; Stevenson MY; Russell WE; Castner BJ; Gerhart MJ; Paxton RJ; Black RA; Chang A; Jackson LF
Ann N Y Acad Sci; 2003 May; 995():22-38. PubMed ID: 12814936
[TBL] [Abstract][Full Text] [Related]
19. Novel mechanistic insights into ectodomain shedding of EGFR Ligands Amphiregulin and TGF-α: impact on gastrointestinal cancers driven by secondary bile acids.
Nagathihalli NS; Beesetty Y; Lee W; Washington MK; Chen X; Lockhart AC; Merchant NB
Cancer Res; 2014 Apr; 74(7):2062-72. PubMed ID: 24520077
[TBL] [Abstract][Full Text] [Related]
20. A disintegrin and metalloproteinase 17 (ADAM17) and epidermal growth factor receptor (EGFR) signaling drive the epithelial response to Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1).
Breshears LM; Schlievert PM; Peterson ML
J Biol Chem; 2012 Sep; 287(39):32578-87. PubMed ID: 22833676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
